Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Dec 26, 2014 (12 years ago)

Dopamine various strengths in dextrose

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of sterility assurance.

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

Dopamine various strengths in dextrose

Drug: Dopamine

Recalling firm
Walgreens Infusion Services
Origin
TX, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0365-2015 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Dopamine recalls

See all
Class II · Moderate risk

Dopamine HCI active pharmaceutical ingredient packaged in varying…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-638-2015
Class II · Moderate risk

DOPamine Hydrochloride and 5% Dextrose INJ

Lack of Assurance of Sterility: A small cut in the solution bag may have been introduced during the manufacturing process, resulting in a leak of the bag into the overpouch.

Terminated Sterility / contamination Baxter Healthcare Corp. NDC 0338-1005-02 D-0004-2015

Other recalls by Walgreens Infusion Services

All 2014 recalls